MoonLake Immunotherapeutics
MLTX
#3375
Rank
NZ$5.86 B
Marketcap
$93.06
Share price
4.74%
Change (1 day)
21.36%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$92.72 Million, an increase over its 2022 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion38.94%
2023 -NZ$92.72 Million-16.81%
2022 -NZ$0.12 Billion